Tickr
Home Explore Daily Brief Market Watchlists Portfolio
Research
Catalysts Signal Factory Screener Market News Event Calendar Valuation Plot Heat Map Top Investors Industry Trends Options
AI Assistant Notifications Account
Evaxion Biotech A/S logo

Evaxion Biotech A/S (EVAX) Stock Ticker

NASDAQ: EVAX · Healthcare · Biotechnology
$3.34+2.45%
USD · as of 2026-09-28 · market cap $21.1M
Open EVAX in TickrDownload for iPhone

Market factors today

Tickr 500 vs S&P 500+0.49%+1.0% MTD
Momentum L/S+1.35%+15.1% MTD
High-beta momo L/S+1.46%+22.2% MTD
Rate sensitivity L/S+1.91%+6.9% MTD
Oil sensitivity L/S-2.54%-5.3% MTD
Unprofitable tech-1.43%+3.7% MTD

Unlock the full EVAX picture

🔒 Implied move chart & probabilities
🔒 Live options flow
🔒 AI analysis & chat on EVAX
🔒 Catalysts & earnings
🔒 Strategy Lab
🔒 Financials & estimates
Start your 7-day free trial

About Evaxion Biotech A/S

Evaxion Biotech A/S is a clinical-stage biotechnology firm dedicated to creating artificial intelligence-driven immunotherapies. Its innovative pipeline targets cancers, bacterial infections, and viral diseases. The company's oncology portfolio features several promising candidates: EVX-01, a leading cancer immunotherapy currently in Phase IIb clinical trials for metastatic melanoma; EVX-02, a DNA-based cancer immunotherapy undergoing Phase IIa trials for adjuvant melanoma; and EVX-03, another DNA-based immunotherapy in development for a range of cancers. Beyond oncology, Evaxion is advancing three pre-clinical vaccine candidates—EVX-B1, EVX-B2, and EVX-V1—aimed at combating various bacterial and viral pathogens. Founded in 2008, Evaxion Biotech A/S is headquartered in Hørsholm, Denmark.

EVAX stock facts

Ticker symbolEVAX
ExchangeNASDAQ Capital Market
SectorHealthcare
IndustryBiotechnology
Market cap$21.1M
CEOHelen Katrina Tayton-Martin
Employees46
HeadquartersHorsholm, ND, DK
IPO date2021-02-05
Websiteevaxion.ai

What you can see for EVAX on Tickr

Live EVAX price chart with overlays, the options chain, implied move, IV rank, options flow and Strategy Lab, financial statements and consensus estimates, analyst ratings, catalysts, news with AI scoring, and an AI chat that has read the EVAX report.

Rankings

Largest Healthcare companiesLargest companies by market cap

FAQ

What is the ticker symbol for Evaxion Biotech A/S?

The ticker symbol for Evaxion Biotech A/S is EVAX, listed on the NASDAQ Capital Market.

What is EVAX?

Evaxion Biotech A/S is a clinical-stage biotechnology firm dedicated to creating artificial intelligence-driven immunotherapies. Its innovative pipeline targets cancers, bacterial infections, and viral diseases. The company's oncology portfolio features several promising candidates: EVX-01, a leading cancer immunotherapy currently in Phase IIb clinical trials for metastatic melanoma; EVX-02, a…

HomeExploreMarketLists
All pages